… Another explanation for our findings could be the use of a warfarin anticoagulation clinic
model, which enables frequent prothrombin time/international normalized ratio monitoring and …

… patients diagnosed with NVAF and stroke risk factors [Citation2]. Warfarin therapy requires
frequent prothrombin time … in the association between hospital LOS and apixaban or warfarin …

… of the activated partial thromboplastin time (aPTT) are less … , a normal aPTT with dabigatran
or a normal PT with apixaban, … In summary, despite the association between drug levels …

… clotting time (ACT) is used to ensure adequate anticoagulation during Atrial Fibrillation (AF) …
DOAC) and vitamin K antagonists in achieving therapeutic ACTs and have demonstrated no …

… well overall with prothrombin time, activated partial thromboplastin time, thrombin time,
and … on dabigatran and not in patients on apixaban treatment (c), and moderately with anti-Xa …

… The statistical analysis for the association between AXA values and PT or APTT was performed
… or non-valvular atrial fibrillation who took factor Xa inhibitors (apixaban, edoxaban, or …

… However, the AHA and American Stroke Association guidelines for the management of …
of apixaban (200 ng/mL). The results showed apixaban administration prolonged clotting time …

… Consecutive 97 NVAF patients under edoxaban therapy were evaluated (60/30 mg …
prothrombin time (PT) with PC-Ed was higher than that of activated partial thromboplastin time (aPTT)…

… Current or future treatment with DXaI for non-valvular atrial fibrillation and adult … association
with both APTT and PT, while a negative correlation was observed with D-dimer in apixaban …

… with non‐valvular atrial fibrillation. … of prothrombin time (PT) (1.66‐fold versus 1.14‐fold)
and activated partial thromboplastin time (APTT) (1.43‐fold versus 1.16‐fold) at steady state than …